Literature DB >> 24613741

Defining prostate cancer risk after radical prostatectomy.

S Adamis1, I M Varkarakis2.   

Abstract

Prostate cancer encompasses a wide spectrum of tumor phenotypes with differing prognoses and a part of these patients are at risk of experiencing tumor recurrence after initial treatment. This review discusses the parameters that determine PCa risk for failure after radical prostatectomy and also focuses on the ability of currently available post-treatment nomograms to predict treatment outcomes, and probability of treatment failure. The use of predictive nomograms may be therefore helpful in the complex decision making process.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adverse features; Predictive nomograms; Prostate cancer; Radical prostatectomy

Mesh:

Substances:

Year:  2014        PMID: 24613741     DOI: 10.1016/j.ejso.2014.02.221

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  8 in total

1.  Three linked nomograms for predicting biochemical failure in prostate cancer treated with radiotherapy plus androgen deprivation therapy.

Authors:  Jose López-Torrecilla; Anna Boladeras; María Angeles Cabeza; Almudena Zapatero; Josep Jove; Luis M Esteban; Ivan Henriquez; Manuel Casaña; Carmen González-San Segundo; Antonio Gómez-Caamaño; Jose Luis Mengual; Asunción Hervás; Julia Luisa Muñoz; Gerardo Sanz
Journal:  Strahlenther Onkol       Date:  2015-07-09       Impact factor: 3.621

Review 2.  Prostate MR Imaging for Posttreatment Evaluation and Recurrence.

Authors:  Sonia Gaur; Baris Turkbey
Journal:  Radiol Clin North Am       Date:  2017-11-27       Impact factor: 2.303

3.  Polymorphic variants of the CASP3, CASP9, BCL-2 and NKX3-1 genes as candidate markers for prostate cancer susceptibility and poor prognosis.

Authors:  Mariana Bisarro Dos Reis; Ilce Mara de Syllos Cólus; Milene Roldão de Souza; Marilesia Ferreira de Souza; Monyse de Nóbrega; Heloísa Lizotti Cilião; Paulo Emílio Fuganti
Journal:  Mol Biol Rep       Date:  2022-06-16       Impact factor: 2.742

Review 4.  Multiparametric Magnetic Resonance Imaging of Recurrent Prostate Cancer.

Authors:  Francesca V Mertan; Matthew D Greer; Sam Borofsky; Ismail M Kabakus; Maria J Merino; Bradford J Wood; Peter A Pinto; Peter L Choyke; Baris Turkbey
Journal:  Top Magn Reson Imaging       Date:  2016-06

5.  Detecting recurrent prostate Cancer using multiparametric MRI, influence of PSA and Gleason grade.

Authors:  Aradhana M Venkatesan; Eniola Mudairu-Dawodu; Cihan Duran; R Jason Stafford; Yuanqing Yan; Wei Wei; Vikas Kundra
Journal:  Cancer Imaging       Date:  2021-01-06       Impact factor: 3.909

Review 6.  Radiation Therapy After Radical Prostatectomy: What Has Changed Over Time?

Authors:  Fabio Zattoni; Isabel Heidegger; Veeru Kasivisvanathan; Alexander Kretschmer; Giancarlo Marra; Alessandro Magli; Felix Preisser; Derya Tilki; Igor Tsaur; Massimo Valerio; Roderick van den Bergh; Claudia Kesch; Francesco Ceci; Christian Fankhauser; Giorgio Gandaglia
Journal:  Front Surg       Date:  2021-07-09

7.  Tumour cell proliferation (Ki-67) in non-small cell lung cancer: a critical reappraisal of its prognostic role.

Authors:  A Warth; J Cortis; A Soltermann; M Meister; J Budczies; A Stenzinger; B Goeppert; M Thomas; F J F Herth; P Schirmacher; P A Schnabel; H Hoffmann; H Dienemann; T Muley; W Weichert
Journal:  Br J Cancer       Date:  2014-07-22       Impact factor: 7.640

8.  Prostate Cancer Detection with a Tactile Resonance Sensor-Measurement Considerations and Clinical Setup.

Authors:  Anders P Åstrand; Britt M Andersson; Ville Jalkanen; Börje Ljungberg; Anders Bergh; Olof A Lindahl
Journal:  Sensors (Basel)       Date:  2017-10-26       Impact factor: 3.576

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.